| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 von Willebrand factor and von Willebrand disease Ruggeri ZM; Zimmerman TSBlood  1987[Oct]; 70 (4): 895-904Progress has occurred in the past several years in the understanding of the  structure and function of von Willebrand factor (vWF). This multimeric  glycoprotein exhibits a dual role, that of mediating platelet adhesion and  aggregation onto thrombogenic surfaces, and that of functioning as carrier in  plasma for the factor VIII procoagulant protein. New insights into the nature of  the several functional domains of vWF have led to the identification of the  regions of the molecule that interact with factor VIII, heparin, the glycoprotein  lb of platelets, and collagen. Alterations of vWF are the cause of von Willebrand  disease (vWD), a congenital bleeding disorder. In the majority of patients, the  plasma levels of vWF are decreased, but there is no demonstrable structural or  functional alteration of the protein. In other patients, however, the structure  of vWF is abnormal. This review summarizes the current knowledge on vWF and vWD.|Chemical Phenomena[MESH]|Chemistry[MESH]|Humans[MESH]|Platelet Aggregation/drug effects[MESH]|Ristocetin/pharmacology[MESH]|von Willebrand Diseases/*classification/etiology/metabolism/physiopathology[MESH]|von Willebrand Factor/biosynthesis/metabolism/*physiology[MESH]
 |